Increasing Investment by Pharmaceutical Companies and Favorable Government Policies has Propelled the Growth of the Peptide and Anticoagulant Drugs Market in the North America Region!
- Vikas Kumar
- July 21, 2023
- HEALTHCARE, NEWS
- 0 Comments
The increased adoption of targeted peptide drugs, rising awareness regarding the availability of peptide therapeutics, and the rising biopharmaceutical industry is driving regional growth. According to the American Cancer Society, “Cancer and Figures 2022”, there was an estimated 1.9 million new cancer cases diagnosed in 2022. Moreover, as per the same source in 2020, the most common cancers were breast (253,465), lung (227,875), prostate (209,512), and colon (101,809) in the U.S. Thus, the increasing cases of cancer require early treatment which is expected to increase the demand for peptide therapeutics over the forecast period. Apart from this, the presence of major key players and rising investments by pharmaceutical companies are also propelling regional market growth.
Access sample report (including graphs, charts, and figures): https://univdatos.com/report/endoscopy-procedures-estimates-market/get-a-free-sample-form.php?product_id=41923
Further, the North America Peptide Therapeutics Market is expected to grow at a strong CAGR of 8.5% during the forecast period (2022-2030). North America held a dominant share in the market in 2021 owing to the increased adoption of targeted therapy and the rise in the incidence of cancer in the U.S. According to the Globocan 2020 report, an estimated 2,281,658 new cancer cases were diagnosed in the U.S in 2020, with nearly 612,390 deaths. Apart from this, the presence of major key players, rising investments by pharmaceutical companies, and favorable government regulatory policies are also propelling regional market growth. For instance, in July 2022, Peptilogics received U.S. FDA fast-track designation for PLG0206, for the treatment of periprosthetic joint infection (PJI).
- Revenue (2020-2028)- USD Mn
For a detailed analysis of the Global Peptide and Anticoagulant Drugs Market browse through :- https://univdatos.com/report/peptide-and-anticoagulant-drugs-market/
Based on application, the market is segmented into cancer, metabolic, cardiovascular disorders, pulmonary embolism, deep vein thrombosis, atrial fibrillation & heart attack, and others. Amongst these, cancer is expected to grow with a high CAGR during the forecast period owing to the high specificity and targetability of peptide therapeutics. Other factors, such as a surge in the prevalence of cancer, rapid product launches, and increasing research and development activities are also driving the segment growth. For instance, in June 2021, Nimble Therapeutics announced a collaboration with RayzeBio to discover and develop novel peptide-based radiopharmaceuticals for the treatment of cancer.
By end-users, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Online pharmacies are expected to register a high CAGR during the forecast period. The demand for the online pharmacy segment is projected to be influenced by factors such as the rise in internet usage, rising telemedicine adoption, rising technology adoption, and convenience and time efficiency. Also, the availability of well-known e-pharmacy players and the savings they provide are expected to support segment demand in the near future.
Global Peptide and Anticoagulant Drugs Market Segmentation
Market Insight, by Application
- Cancer
- Metabolic
- Cardiovascular Disorder
- Pulmonary Embolism
- Deep Vein Thrombosis (DVT)
- Atrial Fibrillation & Heart Attack
- Others
Market Insights, by Route of Administration
- Peptide Drugs
- Parenteral
- Oral
- Mucosal
- Others
- Anticoagulant Drugs
- Oral
- Injectable
Market Insights, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Insight, by Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- APAC
- China
- Japan
- India
- Rest of APAC
- Rest of the World
